Losartan versus atenolol in hypertension and LVH
Diabetes Mellitus, Type 2
Hypertrophy, Left Ventricular
We compared treatment with losartan versus treatment with atenolol in a subgroup of hypertensive patients without clinically evident vascular disease from the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. Treatment with losartan improved outcomes, especially by preventing stroke.